OHRI’s vision is to give our patients and their loved ones new hope through research that is making tomorrow’s health care possible today.
This vision expresses our commitment to research that is focused on and inspired by patients. We approach our work with compassion and dedication each day, knowing that every question we answer and every problem we solve could eventually impact many people, including our own loved ones.
To support our vision, we have developed two strategic research priorities:
Regenerative and biological therapeutics: Fostering bench-to-bedside research by turning basic discoveries in cellular and molecular biology into new regenerative and biological therapeutics to improve health.
Practice-changing research: Putting knowledge to work by performing high quality clinical research that can inform health decisions, and ensuring that results are optimally applied to improve health.
We have also developed a crosscutting strategic research theme on vascular health, which is designed to foster an exciting area of research that focuses on the role of blood vessels in health and disease. This theme cuts across all of our existing programs, fits well with our partners and addresses a major challenge for the health and wellbeing of Canadians.
OHRI is a not-for-profit corporation governed by a Board of Directors that includes members of the University of Ottawa, The Ottawa Hospital and the community.
Ken Newport, Biotech Entrepreneur
Board Vice-Chair and Treasurer
Ian Mumford, Chief Operating Officer, Canadian Blood Services
Board of Directors
Dr. Jacques Bradwejn, Dean, Faculty of Medicine, University of Ottawa
Christa Casey, Partner & Director of the Not-for-Profit Sector Ottawa, Welch LLP
Ian Curry, President and CEO, DNA Genotek
Gary Hannah, President and CEO , Vocantas
Don Hewson, President and CEO, HBS Marketing
Dr. Jack Kitts, President and CEO, The Ottawa Hospital
Louis Lamontagne, Entrepreneur
Sylvie Lauzon, Dean, Faculty of Health Sciences, University of Ottawa
Rose Lipiec Montoya, Financial Planner, TD Waterhouse Financial Planning
Randall Marusyk, Managing Partner, MBM Intellectual Property Law
Dr. Mona Nemer, Vice-President, Research, University of Ottawa
Brian Radburn, CFO, Panacis
Dr. Duncan Stewart, CEO and Scientific Director, Ottawa Hospital Research Institute, Vice-President of Research, The Ottawa Hospital and Professor of Medicine, University of Ottawa
Bashir Surani, Member of The Ottawa Hospital Board of Governors
D. Lynne Watt, Partner, Gowling Lafleur Henderson LLP
Shirley Westeinde, Chair, Westeinde Group of Companies
Senior Management Team
OHRI’s senior management team provides scientific and administrative leadership.
Dr. Duncan Stewart
CEO and Scientific Director
Dr. Rashmi Kothary
Deputy Scientific Director
Dr. Jay Baltz
Associate Scientific Director, Trainees
Dr. Dean Fergusson
Program Director, Clinical Epidemiology
Dr. Antoine Hakim
Program Director, Neuroscience
Chief Operating Officer
Dr. Michael McBurney
Program Director, Cancer Therapeutics
Dr. Leo Renaud
Associate Scientific Director
Dr. Michael Rudnicki
Program Director, Regenerative Medicine
Dr. Alexander Sorisky
Program Director, Chronic Disease